Morgan Stanley’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-599,469
| Closed | -$27.9M | – | 7799 |
|
|
2023
Q2 | $27.9M | Buy |
599,469
+521,832
| +672% | +$24.2M | ﹤0.01% | 2126 |
|
|
2023
Q1 | $2.22M | Sell |
77,637
-6,388
| -8% | -$183K | ﹤0.01% | 4395 |
|
|
2022
Q4 | $2.62M | Buy |
84,025
+45,968
| +121% | +$1.43M | ﹤0.01% | 4278 |
|
|
2022
Q3 | $771K | Buy |
38,057
+5,837
| +18% | +$118K | ﹤0.01% | 5039 |
|
|
2022
Q2 | $500K | Buy |
32,220
+29,547
| +1,105% | +$459K | ﹤0.01% | 5425 |
|
|
2022
Q1 | $51K | Sell |
2,673
-29,858
| -92% | -$570K | ﹤0.01% | 6700 |
|
|
2021
Q4 | $823K | Buy |
+32,531
| New | +$823K | ﹤0.01% | 5218 |
|